EWAF
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
04/01/2025
Voltar para busca
Dado oficial do USPTO
ENTOS
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
41
Atualização mais recente
08/01/2025
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
42
Data de depósito
20/08/2021
Data de registro
29/08/2023
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
29/08/2023
Última transação
08/01/2025
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Fundamento do pedido
Intent to use
Primeiro uso
03/10/2013
Primeiro uso no comércio
03/10/2013
Código do desenho
4
Tipo de titular
03
Localização do titular
EDMONTON, AB, CA
Examinador
MCMORROW, JANICE
Unidade examinadora
M60
Localização atual
PUBLICATION AND ISSUE SECTION
Titulares e representantes
Titulares
ENTOS PHARMACEUTICALS INC.
Entos, Inc.
Representantes
Theodore R. Remaklus Thompson Hine LLP
Classificação técnica
Classes Nice
Classe 42
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 42
research and development in the field of computational biologybioinformaticsgenomics; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; pharmaceuticalmedicalscientificbiotechnologybiopharmaceutical research and development; technical scientific consultation and product development for others in the field of biotechnology and immunology; development of pharmaceuticals; research and development of pharmaceutical preparations and substances for use in clinical trials; scientific and technological servicesresearch and design in the field of computational chemistrymachine learning and artificial intelligence for use in chemistrybiologyphysicsbiochemistrychemical engineeringcomputer sciencedesign and optimization of moleculesmaterialsdrugs; chemistry serviceslaboratory research in the fields of chemistry and design of new chemistry; chemistry services in the nature of drugmolecular discovery servicesproduct development services; chemical research and chemistry consultation in the field of drug and molecular development; industrial analysis and research services being scientific research in the field of drugmaterialsmolecular development; technical data analysis services being technology advisory services relating to computer programs for use in chemistrybiologyphysicsbiochemistrychemical engineeringcomputer sciencethe discovery of new moleculesmaterialsdrugsmachine learning techniques; computer programming in the fields of molecularmaterialsdrug development; computer consultancy services being computer software consultation in the field of drugmaterialsmolecular development; computer software consultation servicesassistance and consulting in connection with the development of computer applicationsdatabases and systems for use in the field of drugmaterialsmolecular development; consulting services in the design and implementation of computer-based information systems for businessprovision of online information relating to computer hardware and software design in the field of drugmaterialsmolecular development; creationmaintenancehostingdesign of websites in the field of drugmaterialsmolecular development; provision of online non-downloadable software for simulations for drugmaterialsmolecular discovery; software as a service (saas) services featuring computer software platforms for use in optimizing drugmaterialsmolecular discovery; platform as a service (paas) featuring computer software platforms for use in optimizing drugmaterialsmolecular discovery; creating website based indexes of information for others using information technology for use in the field of drugmaterialsmolecular development; computer graphics design servicesrealization of computer graphics and digital imaging for use in the field of drugmaterialsmolecular development; scientific research in connection with computerized automation of technical processes for use in the field of drugmaterialsmolecular development; cloud-based computing featuring software for optimizing the development of new molecules and designing and discovering moleculesdrugsbattery materialsother molecular products
Publicações
Histórico de despachos e eventos da marca no USPTO.
41 publicações encontradas
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
04/01/2025
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
04/01/2025
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
04/01/2025
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
04/01/2025
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
04/01/2025
EWAF
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
01/09/2023
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
01/09/2023
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
01/09/2023
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
01/09/2023
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
01/09/2023
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
01/09/2023
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
01/09/2023
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
30/08/2023
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
29/08/2023
R.PR
REGISTERED-PRINCIPAL REGISTER
29/08/2023
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
27/07/2023
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
26/07/2023
SUPC
STATEMENT OF USE PROCESSING COMPLETE
25/07/2023
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
24/07/2023
IUAF
USE AMENDMENT FILED
30/06/2023
EISU
TEAS STATEMENT OF USE RECEIVED
30/06/2023
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
13/06/2023
ETOP
EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
04/05/2023
ETOF
EXTENSION OF TIME TO OPPOSE RECEIVED
27/10/2022
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
25/10/2022
PUBO
PUBLISHED FOR OPPOSITION
25/10/2022
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
05/10/2022
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
20/09/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
17/09/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
16/09/2022
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
16/09/2022
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
23/05/2022
GNRT
NON-FINAL ACTION E-MAILED
23/05/2022
CNRT
NON-FINAL ACTION WRITTEN
23/05/2022
DOCK
ASSIGNED TO EXAMINER
23/05/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
07/10/2021
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
08/09/2021
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
08/09/2021
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
08/09/2021
NWAP
NEW APPLICATION ENTERED
24/08/2021
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace ENTOS ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.